Cite
APA Citation
Qin, S., Chan, S. L., Sukeepaisarnjaroen, W., Han, G., Choo, S. P., Sriuranpong, V., Pan, H., Yau, T., Guo, Y., Chen, M., Ren, Z., Xu, J., Yen, C., Lin, Z., Manenti, L., Gu, Y., Sun, Y., Tiedt, R., Hao, L., Song, W., & Tanwandee, T. (2019). a phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma. Therapeutic advances in medical oncology, 11, . http://access.bl.uk/ark:/81055/vdc_100099956575.0x00013e